Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach New Heights
Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Uveitis is swelling of the middle layer of the eye, which is called the uvea. It may occur from both infectious and non-infectious causes. It is a group of inflammatory diseases affecting eyes and can cause loss of vision. Causes of uveitis include infections such as brucellosis, leptospirosis, syphilis, tuberculosis, autoimmune diseases such as sarcoidosis, Crohn’s disease, multiple sclerosis, arthritis, ankylosing spondylitis, and psoriatic arthritis. In addition, uveitis is also caused by drugs such as Rifabutin and moxifloxacin.
The growth of uveitis drugs market is due to rise in prevalence and complications related to uveitis. In addition, increase in prevalence rates, market players betting heavily on R & D to develop new drugs, an introduction of biologics into the market, fast approval of the drugs are fueling the market growth of global uveitis treatment market. However, few factors are restraining the growth of the market such as side effects of the drugs, eye irritation and lack of awareness about eye disorders in undeveloped regions, lack of sufficient healthcare infrastructure is hindering the non-infectious uveitis treatment market.
The global uveitis treatment market is categorized as-
Type of cause
Hospital Pharmacies, retail pharmacies and others
And lastly on the basis of geographical regions global uveitis treatment market segmented into following regions-North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is leading in global uveitis treatment market due to various factors such as early approval of drugs compared to other regions, increased R & D investments by market players, and high prevalence of the uveitis is contributing growth of the market. In Europe region due to increased prevalence of diseases such as HIV, multiple sclerosis that are underlying causes of uveitis conditions. Japan, China, and India are expected to play important role in the revenue growth of the Asia-Pacific uveitis treatment market due to rapidly developing healthcare infrastructure, increased R & D expenditure and growing awareness about the eye-related diseases. However, manufacturing of eye preparations required aseptic conditions and the manufacturing plant should be GMP certified. Hence the cost related to these preparations is very high that has the direct implication on a cost of the drugs.
Some of the key players in uveitis drugs market include AbbVie Inc. (U.S.), Eyegate Pharmaceuticals Inc. (US), Valeant Pharmaceuticals (Bausch + Lomb) (Canada), Novartis AG (Switzerland), Alimera Sciences Inc. (U.S.) and Santen Pharmaceutical Co. Ltd (Japan) to name a few. In 2016, USFDA approved AbbVie’s HUMIRA for the treatment of non-infectious intermediate, posterior and Panuveitis.
Market players are developing novel molecules that can treat uveitis conditions in order to enhance their sales revenue. Companies are focusing on the development of the various drugs in the treatment of the Uveitis. For instance, Aurinia Pharmaceuticals Inc. developing Luvenia, a calcineurin inhibitor for the treatment of noninfectious Uveitis. Considering the above-mentioned factors non-infectious uveitis treatment market is expected to grow at the significant rate.
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach New Heights here
News-ID: 1207384 • Views: 452
More Releases from Precision Business Insights
Directed Energy Weapons Market 2022 | Industry Outlook, Size, Share and Growth A …
According to Precision Business Insights (PBI), the latest report, the market value of the directed energy weapons market size is expected to be valued at USD 4,564.8 million in 2022 and is expected to grow at a CAGR of 19.1% in 2022-2028. The primary factors that drive the market are increasing funding in research and developmental events to introduce technologically advanced products, growing upgradation in military stages and apparatus, and
Broaching Machine Market Growing Demand, Opportunities and Share Analysis 2022 t …
According to Precision Business Insights (PBI), the latest report, the market value of the broaching machine market size is expected to be valued at USD 284.6 million in 2022 which is expected to grow at a CAGR of 6.1% from 2022-2028. The primary factors that drive the market are the rising demand from aerospace and automotive industries and the requirement for fabricated metal products and high-accuracy systems. View the detailed report
Thermoforming Plastic Market Growing Demand, Opportunities and Share Analysis 20 …
According to Precision Business Insights (PBI), the latest report, the market value of the thermoforming plastic market size is expected to be valued at USD 14.5 billion in 2022 and is expected to grow at a CAGR of 5.2% in 2022-2028. The primary factors that drive the market are growing disposable income, the use of thermoforming plastic in food and healthcare industries for packaging purposes, and growing demand for the
Stucco Market Growing Demand, Opportunities and Share Analysis 2022 to 2028
According to Precision Business Insights (PBI), the latest report, the market value of the stucco market size is expected to be valued at USD 11.2 billion in 2022 which is expected to grow at a CAGR of 4.5% over 2022-2028. The primary factors that drive the market are rising urbanization, lifestyle changes, and the wish for enhanced aesthetics in commercial and residential buildings have inspired engineers and architects to modernize
More Releases for Uveitis
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and
Global Uveitis Treatment Market Industry Analysis and Forecast
Market Research Reports Search Engine (MRRSE) has included a new study titled, “Global Market Study on Uveitis Treatment-Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”.Persistence Market Research presents a comprehensive study of the global uveitis treatment market in a new publication titled “Uveitis Treatment Market: Global Industry Analysis and Forecast, 2016–2024.” The report forecasts the performance of the global uveitis treatment market across different geographical locations and critically